PSA-TRICOM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PSA-TRICOM, covering 2020-09-16 to 2020-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer [Phase 2]